AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06751316 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: MTA Pulpotomy
Description: Removal of coronal pulp tissue, placing MTA and covered by stainless steel crown
Study NCT06748807 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: APRVplus
Description: Early Pathophysiology-driven Airway Pressure Release Ventilation (APRVplus)
Study NCT06748807 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: TCAV
Description: Time-Controlled Adaptive Ventilation (TCAV)
Study NCT06749626 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: progressive relaxation exercise
Description: Relaxation exercises CD developed by the Turkish Psychologists Association; It consists of muscle exercises, rhythmic breathing and music recital. The CD content, which includes relaxation exercises accompanied by music, was prepared by Psychologist Elif Kabak and voiced by Tülay Bursa. The CD, which includes deep breathing and muscle relaxation exercises, consists of three parts. The first section includes the definition of deep relaxation, the purpose of relaxation exercises and the rules to be considered in exercise practice. In the second part; There are relaxation exercises with audio instructions accompanied by streaming sounds. The third part contains relaxation music without instructions. After the information in the first part of the CD is explained to the patients in the experimental group, the second part, which lasts only approximately 30 minutes, will be administered under the supervision of the researcher. However, since the patients have undergone abdominal surgery, the
Study NCT06748235 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Intensive Strength Training
Description: Comprehensive Hand Repetitive Intensive Strength Training and Routine Physical Therapy 60 minutes per session, three sessions a week, at a total of 30 sessions per ten weeks. Comprehensive hand repetitive intensive strength training included treadmill training for the upper limb with body weight supporting the using upper limb. The posture of an arm swing was to maintain the joints of the elbows and wrist as much as possible, and the shoulder joint was allowed to be flexed by 160 degrees .The posture of the arm stance supported the weight using metacarpal heads, hands, and elbows, and the shoulder joints were allowed to be flexed by 90 degrees.
Study NCT06748235 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Routine Physical Therapy
Description: Received 60 minutes per a session, three sessions a week, at a total of 30 sessions per 10 weeks by creating a home program, which consisted of a total of 8 exercises that enhanced the muscular strength of the upper limb including the triceps brachii and extensor carpi radialis, and conveyed an effect of reaching the muscles out. flexion and extension muscle strengthening with towel, hand grip and wrist extension muscle strengthening This exercise consisted of shoulder extension muscle, elbow flexion muscle, shoulder abduction muscle, and elbow extension muscle strengthening with a thera band, as well as hand grip, forearm with a velcro board, wrist extension muscle strengthening with sandbag and shoulder abduction-extension muscle strengthening with a thera band.
Study NCT06750575 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Invasive measurements
Description: Blood and urine samples will be collected during the study.
Study NCT06749964 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Internet-delivered, therapist-assisted, pain-focused CBT based on the psychological flexibility model for chronic pain
Description: 8-session intervention, twice weekly for the first 3 weeks and once weekly for the final 2 weeks (45-60 min each session) aimed at promoting psychological flexibility. Treatment involves a mixture of video and audiotaped presentations and homework activities for the participant.
Study NCT06750588 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: bacteriophage preparation
Description: NTR-101 will be given orally to participants once daily for 7 days
Study NCT06750588 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bacteriophage preparation
Description: NTR-101 will be given orally to participants once daily for 7 days
Study NCT06750588 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: bacteriophage preparation
Description: NTR-101 will be given orally to participants twice daily for 7 days
Study NCT06750588 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: bacteriophage preparation
Description: NTR-101 will be given orally to participants three times daily for 7 days
Study NCT06746675 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Healthy Families PrEP Counselling Intervention
Description: Healthy Families-PrEP intervention with HIV-uninfected women with plans for pregnancy in the next year and concerns about or exposure to HIV. Session 1 focuses on providing information about HIV prevention in the context of reproductive goals (using tools with locally developed images), increasing motivation for behavior change, and developing a safer conception plan (e.g., PrEP uptake, PrEP adherence, couples-based counselling and testing, delaying condomless sex until partner serostatus known and, if living with HIV, virally suppressed). Sessions 2 and 3 (conducted at 1 and 3 months) review the safer conception plan and revise as needed (e.g., changes in readiness to initiate PrEP, partner serostatus knowledge) and engaging in problem-solving barriers (including structural) to plan execution, communication skills training, and motivational strategies for successful plan execution. Participants receive quarterly adherence counseling using tools developed by this team.
Study NCT06746675 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: No intervention (standard of care)
Description: Uganda Ministry of Health Standard of Care
Study NCT05190913 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Instrumental perineal massage
Description: In the active phase of labor, perineal massage will be performed with an instrument twice with an interval of one hour.
Study NCT05190913 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: manual perineal massage
Description: In the active phase of labor, manual perineal massage is performed twice an hour apart.
Study NCT01004315 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study NCT01004315 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tolterodine
Study NCT04761471 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: TI transcranial electrical stimulation
Description: Participants will undergo transcranial electrical stimulation, which will be delivered with low current amplitudes (\<= 2 mA) established with international safety guidelines for electrical stimulation. Threshold for the current amplitude will be established by participants themselves, such that they cannot distinguish when stimulation is applied and not applied.~Duration of stimulation will not last longer than 30 minutes.
Study NCT05258851 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ceftazidime-avibactam
Description: Experimental
Study NCT05258851 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Colistin
Description: Control
Study NCT05943041 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GB104(Level 1)
Description: One capsule QD oral administration for 28 days
Study NCT05943041 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GB104(Level 2)
Description: Three capsules QD oral administration for 28 days
Study NCT05943041 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GB104(Level 3)
Description: Five capsules QD oral administration for 28 days
Study NCT05247073 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: patients of controlled group with routine closure of episiotomy
Description: Perineal trauma is traditionally repaired in three stages: a continuous locking stitch is inserted to close the vaginal trauma, commencing at the apex of the wound and finishing at the level of the fourchette with a loop knot. The perineal muscles are then re-approximated with three or four interrupted sutures and finally, the perineal skin is closed by inserting continuous subcutaneous or interrupted transcutaneous stitches.~The skin is then closed with inverted interrupted stitches placed in the subcutaneous tissue a few millimeters under the perineal skin edges (not transcutaneously).
Study NCT05247073 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: The Mostafa Maged four-stitch technique fore closure of the episiotomy
Description: Identification of the apex of the episiotomy, then a simple suture is taken (0.5 cm) behind the apex of the episiotomy. First, the needle is inserted at the vaginal mucosa of the right edge of the episiotomy then extract the needle.~The second stitch is inserted on the deep muscle layer of the same side (Right side) of the episiotomy cutting edge then extracting the needle.~Then, insert the needle again on the left side of the episiotomy incision in the deep muscle layer on the left side of the episiotomy incision directing the tip of the needle upwards parallel to the second stitch taken.~The fourth step is inserting the needle in the vaginal mucosa of the left side parallel to the first stitch. Continue suturing the episiotomy incision continuously in the same way till reaching the remnant of the hymen.~Then suture the superficial perineal muscle in a continuous manner and the skin in a subcuticular manner as well.
Study NCT06467578 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Breezing Portable Indirect Calorimeter
Description: Indirect calorimeter with face mask and smartphone compatible application
Study NCT06354062 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Talent management intervention program
Description: Talent management intervention program
Study NCT06142669 — intervention group
Intervention type: DEVICE
Intervention: EVOLUTION® Revision Tibial System and EVOLUTION® Stemmed CS Femur with the EVOLUTION® MP CS Tibial Insert
Description: Primary knee arthroplasty or a revision knee that requires a revision procedure.
Study NCT05016687 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CUR-N399
Description: CUR-N399 will be administered as oral capsules.
Study NCT05016687 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo capsules matching CUR-N399 will administered.
Study NCT06750848 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Chidamide，Fulvestrant，angiogenesis inhibitors
Description: chidamide，30mg，po. biw fulvestrant ，500mg， im., d1(c1d15), q4w angiogenesis inhibitors , according to the doctor's advice
Study NCT06748378 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Conventional rehabilitation, the Erigo®Pro table, motor imagery on gait.
Description: 66 stroke patients were randomly assigned to three groups (22 people each) with different therapies (conventional, with the addition of Erigo®Pro and enriched with motor imagery). The therapy duration was two weeks. Patients underwent assessment before and after completion of therapy. The study used the Trunk Stability Test, and the Riablo device to measure gate parameters. Additionally, an evaluation of the superficial tension of the transverse abdominis and multifidus muscles was conducted.
Study NCT06748378 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Conventional rehabilitation, the Erigo®Pro table, motor imagery on gait parameters.
Description: 66 stroke patients were randomly assigned to three groups (22 people each) with different therapies (conventional, with the addition of Erigo®Pro and enriched with motor imagery). The therapy duration was two weeks. Patients underwent assessment before and after completion of therapy. The study used the Trunk Stability Test, and the Riablo device to measure the gate parameters. Additionally, an evaluation of the superficial tension of the transverse abdominis and multifidus muscles was conducted.
Study NCT06751303 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Patients that are HRP are given a decision aid for PARPi use
Description: Study created patient decision aid if the first for HRD tested Ovarian Cancer patients
Study NCT04705805 — intervention group
Intervention type: BEHAVIORAL
Intervention: Self-assessment of olfactory disorders through two questionnaires.
Description: * Assessment of sense of smell or loss of smell using an Analogue Visual Scale~* Carrying out the objective smell test (Sniffin' sticks test) (gold standard)~* Information from two self-questionnaires translated into French: a quality of life questionnaire (The Questionnaire Olfactory Disorders (QOD)) and a self-assessment questionnaire of his olfactory capacities (Self-Mini Olfactory Questionnaire (Self-MOQ))
Study NCT05287373 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Nalu Neurostimulation System for PNS
Description: The Nalu Neurostimulation System for PNS is a peripheral nerve stimulator
Study NCT05287373 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: conventional medical management
Description: Conventional medical management
Study NCT05287373 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: conventional medical management
Description: Conventional medical management
Study NCT05868265 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Enfortumab Vedotin
Description: All patients will receive enfortumab vedotin at 1.25 mg/kg on days 1 and 8 of 21 days cycle, for a total of three cycles.
Study NCT05868265 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Radical surgery
Description: Radical surgery, such as radical nephroureterectomy, nephrectomy or ureterectomy is to take place within 60 days from the last dose of treatment end of cycle 3 (i.e., cycle 3 day 22).
Study NCT05584046 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: CDAM
Description: Novel drugs such as Traditional Chinese Medicine (TCM) formula that can suppress inflammation may augment tissue healing and reduce activity-related pain in patients suffering from plantar fasciitis. Our team has experiences of using TCM for the treatment of plantar fasciitis. Based on our previous experience, our group has developed a new proprietary topical TCM herbal formula, CDAM, containing Carthami Flos , Dipsaci Radix , Aconiti Lateralis Radix Praeparata and Herba Menthae for the treatment of plantar fasciitis.
Study NCT04977271 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Venlafaxine
Description: The Immediate Release generic formulation of this drug will be used due to its ability to be crushed for those patients who rely on parenteral administration of medications.
Study NCT06450977 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: MIND Diet
Description: Daily meals designed to increase adherence to the Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) dietary pattern.
Study NCT04120766 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nicorandil
Description: 20 mg po qd
Study NCT04120766 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Matching tablet
Study NCT05725031 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ephedrine
Description: 70 μg/kg as pretreatment
Study NCT06450977 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Control Diet
Description: Daily meals designed to increase fruit, vegetable, and whole grain intake consistent with a healthy American diet.
Study NCT06097429 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: blood sample for platelet aggregation
Description: evaluate platelet aggregation using light-transmission aggregometry and adenosine diphosphate (ADP)
Study NCT06553222 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Putty bone - Tricalcium phosphate with Collagen gel
Description: Minimally invasive debridement periodontal flap and Bone graft placement to augment the lost alveolar bone
Study NCT06042699 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Oral ferrous sulfate
Description: Oral ferrous sulfate 325mg is used as a dietary supplement providing 65mg elemental iron.
Study NCT06553222 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Putty bone - Tricalcium phosphate with Collagen gel
Description: Minimally invasive debridement periodontal flap and Bone graft placement to augment the lost alveolar bone
Study NCT05725031 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rocuronium 0.6
Description: 0.6 mg/kg
Study NCT05725031 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rocuronium 0.8
Description: 0.8 mg/kg
Study NCT05725031 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Rocuronium 1.2
Description: 1.2 mg/kg
Study NCT04731467 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CM-24 and Nivolumab - Dose Escalation
Description: Dose escalation of CM24 with nivolumab in adult patients with selected recurrent or metastatic solid tumors
Study NCT04731467 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CM-24, Nivolumab, Nab paclitaxel and Gemcitabine - Expansion
Description: Expansion cohort of CM24 in combination with nivolumab, nab-paclitaxel and gemcitabine in adult patients with advanced metastatic pancreatic cancer
Study NCT04731467 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CM-24, Nivolumab, and Nal-IRI/5-FU/LV - Expansion
Description: Expansion cohort of CM24 in combination with nivolumab and Nal-IRI/5-FU/LV in adult patients with advanced metastatic pancreatic cancer
Study NCT04731467 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Nivolumab, Nab paclitaxel and Gemcitabine - Expansion
Description: Expansion cohort of nivolumab in combination with nab-paclitaxel and gemcitabine in adult patients with advanced metastatic pancreatic cancer
Study NCT04731467 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Nivolumab and Nal-IRI/5-FU/LV - Expansion
Description: Expansion cohort of nivolumab in combination with Nal-IRI/5-FU/LV in adult patients with advanced metastatic pancreatic cancer
Study NCT06330493 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: PCB
Description: Paclitaxel coated PTA balloon catheter
Study NCT06330493 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: PTA
Description: Non-coated FDA cleared standard percutaneous transluminal angioplasty balloon catheter
Study NCT04272034 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: INCB099318
Description: INCB099318 administered orally in 20 mg or 100 mg tablets once daily or twice daily on each day of each 28-day cycle.
Study NCT06627049 — intervention group
Intervention type: OTHER
Intervention: Focus group
Description: Focus group to evaluate the facilitators and barriers to the use of virtual reality.
Study NCT06627049 — intervention group
Intervention type: OTHER
Intervention: Implementing facilitating strategies
Description: Implement strategies to facilitate the integration of virtual reality into rehabilitation sessions.
Study NCT06627049 — intervention group
Intervention type: OTHER
Intervention: Focus group
Description: Evaluate the strategies used to facilitate VR implementation.
Study NCT06627049 — intervention group
Intervention type: OTHER
Intervention: Interviews
Description: Interviews to evaluate the facilitators and barriers to the use of virtual reality.
Study NCT06627049 — intervention group
Intervention type: OTHER
Intervention: Interviews
Description: Evaluate the strategies used to facilitate VR implementation.
Study NCT06135090 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Trauma Recovery Program (official title TBD)
Description: See arm description
Study NCT06432842 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Laser Treatment
Description: In the study group, low-dose laser treatment was applied in addition to conventional treatment. Chattanoga Group Therapeutic Laser device was used for laser treatment. Laser treatment was applied to 8 sensitive points around the knee for 1 minute, for a total of 8 minutes. Laser treatment was applied continuously, with a wavelength of 830nm and a power of 6J.
Study NCT06042699 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Oral placebo tablet
Description: Oral placebo tablet provided as placebo comparator.
Study NCT05678413 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: DVIU with paclitaxel injection
Description: Cystourethroscopy will be performed using a 22 Fr rigid cystoscope to allow for ureteric catheter 3F/a wire to be passed through the stricture and into the urinary bladder. DVIU will be performed by cold-knife incisions at the 12-, 3-, and 9 o'clock positions through the full thickness of the fibrosis to healthier appearing tissue. A 23 Fr Wolf (Vernon Hills, IL) injection scope and a standard injection needle was used to inject 30 mg/5mL of paclitaxel vial, 1.5 mL will be injected along the length of each incision into healthier appearing tissue for a total of 5 mL.
Study NCT05678413 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: DVIU
Description: DVIU
Study NCT04855123 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: retinal imaging
Description: OCT-angiography, Retinophotography, ocular fundus, Pulsed air tonometer
Study NCT04855123 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: paraclinical surveillance
Description: blood and urine sampling, assessment of kidney function with creatinine, protein, albumin levels and CKD-EPI equation)
Study NCT05048823 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Visceral Osteopathic Techniques
Description: Generalized Discharge Technique of the Peritoneum and Intestinal Wings, Mobilization of the Cecum, Technique for the Root of the Mesentery, Release of the D1-D2 Angle, Technique for the Sigmoid Colon
Study NCT05048823 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Simulated visceral techniques
Description: Simulated visceral techniques in the region of the gastrointestinal system